年轻女性三阴性乳腺癌中波形蛋白免疫表达强度与临床病理参数的相关性

Q2 Medicine Medicinski arhiv Pub Date : 2022-12-01 DOI:10.5455/medarh.2022.76.454-457
Fitriani Lumongga, Ridha Dharmajaya, Kamal Basri Siregar, Delyuzar, Diah Rini Handjari, Nelva Karmila Jusuf, Delfitri Munir, Asrul
{"title":"年轻女性三阴性乳腺癌中波形蛋白免疫表达强度与临床病理参数的相关性","authors":"Fitriani Lumongga,&nbsp;Ridha Dharmajaya,&nbsp;Kamal Basri Siregar,&nbsp;Delyuzar,&nbsp;Diah Rini Handjari,&nbsp;Nelva Karmila Jusuf,&nbsp;Delfitri Munir,&nbsp;Asrul","doi":"10.5455/medarh.2022.76.454-457","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Young breast cancer patients (≤40 years) have different unifying oncogenic signaling pathways when compared to older people. Vimentin is a filament intermediate. Vimentin expression has an important role in epithelial-to-mesenchymal transition (EMT) and cancer progression.</p><p><strong>Objective: </strong>The aim of this study was to assess the correlation between vimentin intensity and clinicopathological parameters in patients with triple negative breast cancer aged 40 years.</p><p><strong>Methods: </strong>Samples were taken from 45 paraffin blocks of patients with young woman with triple negative invasive breast cancer NOS type that met the inclusion criteria, immunohistochemical examination was performed with vimentin. Vimentin intensity was assessed using ImageJ analysis.</p><p><strong>Results: </strong>Samples were taken from paraffin blocks of patients with triple negative invasive breast cancer NOS type that met the inclusion criteria, immunohistochemical examination was performed with vimentin. Vimentin intensity was assessed using ImageJ analysis.</p><p><strong>Conclusion: </strong>This study shows that vimentin intensity is strongly associated with tumor progression, tumor mass size and tumor invasion so that it can be used as a prognostic factor in young triple negative breast cancer patients.</p>","PeriodicalId":18421,"journal":{"name":"Medicinski arhiv","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/87/1f/medarch-76-454.PMC10019877.pdf","citationCount":"1","resultStr":"{\"title\":\"Correlation Between Intensity of Vimentin Immuno-expression in Young Women with Triple Negative Breast Cancer and Its Cliniocopathological Parameters.\",\"authors\":\"Fitriani Lumongga,&nbsp;Ridha Dharmajaya,&nbsp;Kamal Basri Siregar,&nbsp;Delyuzar,&nbsp;Diah Rini Handjari,&nbsp;Nelva Karmila Jusuf,&nbsp;Delfitri Munir,&nbsp;Asrul\",\"doi\":\"10.5455/medarh.2022.76.454-457\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Young breast cancer patients (≤40 years) have different unifying oncogenic signaling pathways when compared to older people. Vimentin is a filament intermediate. Vimentin expression has an important role in epithelial-to-mesenchymal transition (EMT) and cancer progression.</p><p><strong>Objective: </strong>The aim of this study was to assess the correlation between vimentin intensity and clinicopathological parameters in patients with triple negative breast cancer aged 40 years.</p><p><strong>Methods: </strong>Samples were taken from 45 paraffin blocks of patients with young woman with triple negative invasive breast cancer NOS type that met the inclusion criteria, immunohistochemical examination was performed with vimentin. Vimentin intensity was assessed using ImageJ analysis.</p><p><strong>Results: </strong>Samples were taken from paraffin blocks of patients with triple negative invasive breast cancer NOS type that met the inclusion criteria, immunohistochemical examination was performed with vimentin. Vimentin intensity was assessed using ImageJ analysis.</p><p><strong>Conclusion: </strong>This study shows that vimentin intensity is strongly associated with tumor progression, tumor mass size and tumor invasion so that it can be used as a prognostic factor in young triple negative breast cancer patients.</p>\",\"PeriodicalId\":18421,\"journal\":{\"name\":\"Medicinski arhiv\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/87/1f/medarch-76-454.PMC10019877.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicinski arhiv\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5455/medarh.2022.76.454-457\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinski arhiv","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/medarh.2022.76.454-457","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

摘要

背景:年轻乳腺癌患者(≤40岁)与老年人相比具有不同的统一致癌信号通路。维明蛋白是一种长丝中间体。Vimentin表达在上皮-间质转化(EMT)和癌症进展中起重要作用。目的:本研究的目的是评估40岁三阴性乳腺癌患者波形蛋白强度与临床病理参数的相关性。方法:取45例符合入选标准的年轻女性三阴性浸润性乳腺癌NOS型患者石蜡切片,应用vimentin进行免疫组化检查。采用ImageJ分析评估波形蛋白强度。结果:取符合入选标准的三阴性浸润性乳腺癌NOS型患者石蜡块标本,用vimentin进行免疫组化检查。采用ImageJ分析评估波形蛋白强度。结论:本研究表明,vimentin强度与肿瘤进展、肿瘤体积大小和肿瘤侵袭程度密切相关,可作为年轻三阴性乳腺癌患者的预后因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Correlation Between Intensity of Vimentin Immuno-expression in Young Women with Triple Negative Breast Cancer and Its Cliniocopathological Parameters.

Background: Young breast cancer patients (≤40 years) have different unifying oncogenic signaling pathways when compared to older people. Vimentin is a filament intermediate. Vimentin expression has an important role in epithelial-to-mesenchymal transition (EMT) and cancer progression.

Objective: The aim of this study was to assess the correlation between vimentin intensity and clinicopathological parameters in patients with triple negative breast cancer aged 40 years.

Methods: Samples were taken from 45 paraffin blocks of patients with young woman with triple negative invasive breast cancer NOS type that met the inclusion criteria, immunohistochemical examination was performed with vimentin. Vimentin intensity was assessed using ImageJ analysis.

Results: Samples were taken from paraffin blocks of patients with triple negative invasive breast cancer NOS type that met the inclusion criteria, immunohistochemical examination was performed with vimentin. Vimentin intensity was assessed using ImageJ analysis.

Conclusion: This study shows that vimentin intensity is strongly associated with tumor progression, tumor mass size and tumor invasion so that it can be used as a prognostic factor in young triple negative breast cancer patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medicinski arhiv
Medicinski arhiv Medicine-Medicine (all)
CiteScore
2.10
自引率
0.00%
发文量
54
期刊最新文献
Secretome of Hypoxia-Preconditioned Mesenchymal Stem Cells Enhance Angiogenesis in Diabetic Rats with Peripheral Artery Disease. Perforated Stress Ulcer of the Duodenum: a Case of an Unexpected Diagnosis in a COVID-19 Patient Following Dilatation and Curettage Procedure. Obturator Nerve Block for Transurethral Resection of Bladder Tumors. The Importance of Prediabetes Screening in the Prevention of Cardiovascular Disease. The Correlation of Positive and Negative Symptoms (PANSS Scores) in Patients with Schizophrenia According to Gender.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1